Saeed M, Ahmad S, Hayat A, Saeed S
FY1 Trainee, The Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, West Midlands.
CT1 in General Medicine, Alexandra Hospital, Redditch, West Midlands.
Acute Med. 2014;13(2):86-9.
Hyponatraemia is the most common electrolyte anomaly and is associated with significant morbidity and mortality. Patients with severe hyponatraemia often present to acute medical units with non-specific symptoms which can progress to overt neurological manifestations. There are many causes of hyponatriaemia, the most common being drug-induced causes, particularly thiazide diuretics, and the Syndrome of Inappropriate ADH Secretion (SIADH). Initial assessment should include a careful evaluation of the patient's volume status, which helps to identify the most likely cause. This article utilises a recent case which presented to our AMU to illustrate the importance of a careful and systematic assessment of patients presenting to hospital with hyponatraemia. The new vasopressin receptor antagonists are explored as an option for the management of severe hyponatraemia.
低钠血症是最常见的电解质异常,与显著的发病率和死亡率相关。重度低钠血症患者常因非特异性症状就诊于急性内科病房,这些症状可能进展为明显的神经表现。低钠血症有多种病因,最常见的是药物性病因,尤其是噻嗪类利尿剂,以及抗利尿激素分泌不当综合征(SIADH)。初始评估应包括对患者容量状态的仔细评估,这有助于确定最可能的病因。本文通过近期我院急性内科病房收治的一例病例,阐述对低钠血症住院患者进行仔细系统评估的重要性。探讨了新型血管加压素受体拮抗剂作为重度低钠血症治疗选择的可能性。